Skip to content

Safety and efficacy of skincare formulation

To evaluate the in-vivo efficacy and safety of hair care formulation in terms of reduction in Hair Fall and Anti-dandruff effects on healthy male & female subjects - N/AP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039138
Enrollment
36
Registered
2022-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: BRND OIL â?? VR (VR-02) : Product A: Application will be done on scalp and shafts, twice a week for the period of 28 days. Control Intervention1: NIL: NIL

Sponsors

Kama Ayurveda Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Having moderate to severe hair fall. Having Moderate to severe dandruff where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4 is Severe Suffering with hair thinning on subject assessment basis. For female: Having at least shoulder length hair. Having washed their hair with provided neutral shampoo, 48 hours before the first day of the study with the provided nuetral shampoo. Having untangled their hair at home, 3 hours prior coming to the site for observations, the first day of the study.

Exclusion criteria

Exclusion criteria: Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze) Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study Having surgery history on the scalp (micro transplants â?¦) In the previous 6 months - Having undergone the Minoxidil treatments - Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide) - Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids â?¦ - Having modified her hormonal contraception In the previous 3 months - Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc â?¦) - Having taken a food supplement with an anti hair loss claim - Having taken an iron based treatment In the previous 15 days - Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim

Design outcomes

Primary

MeasureTime frame
efficacy of hair care formulation in terms of reduction in Hair Fall and Anti-dandruff effectTimepoint: T0, T14 days and T28 days

Secondary

MeasureTime frame
SafetyTimepoint: T0, T14 days and T28 days

Countries

India

Contacts

Public ContactMr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026